US Stock MarketDetailed Quotes

LPTX Leap Therapeutics

Watchlist
  • 2.9100
  • +0.1300+4.68%
Close Dec 20 16:00 ET
  • 3.0700
  • +0.1600+5.50%
Post 19:55 ET
111.51MMarket Cap-1.77P/E (TTM)

Leap Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Leap Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 3 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 0.000--
--2024/Q4-- / 0.000--
--2024/Q30.000 / 0.000--
--2024/Q20.000 / 0.000--
--2024/Q10.000 / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 0.000--
--2024/Q4-- / 0.000--
--2024/Q30.000 / 0.000--
--2024/Q20.000 / 0.000--
--2024/Q10.000 / 0.000--

Unlock Free Earnings Estimates

Leap Therapeutics Earnings Reports

  • Leap Therapeutics | 8-K: Leap Therapeutics Reports Third Quarter 2024 Financial Results

    Nov 13 20:13

  • Leap Therapeutics | 10-Q: Q3 2024 Earnings Report

    Nov 13 19:52

  • Leap Therapeutics | 8-K: Leap Therapeutics Reports Second Quarter 2024 Financial Results

    Aug 12 19:15

  • Leap Therapeutics | 10-Q: Q2 2024 Earnings Report

    Aug 12 18:56

    • Read more

    Analysis

    Analyst Rating

    Updated: Nov 30, 2024

    Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Price
    % Chg

    No Data